Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
MAIA Biotechnology, Inc. shareholders approved Ratification of Auditors at the 2026-05-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Stockholders ratified the appointment of Grant Thornton LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: For Against Abstain 37,278,294 210,408 19,052
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
MAIA Biotechnology, Inc. shareholders approved Election of Class I Directors at the 2026-05-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Stockholders re-elected both of the Company’s Class I nominees for director for three-year terms expiring on the annual meeting of stockholders to be held in 2029 or until their successors are duly elected and qualified. Each of the nominees is currently serving as a member of our board of directors. The voting results were as follows: Directors For Withheld Broker Non-Votes Louie Ngar Yee 16,658,677 8,796,832 11,375,414 Steven Chaouki 25,109,811 345,698 11,375,414
View on SEC.gov